{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T01:29:58Z","timestamp":1763429398491,"version":"3.44.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ad.2016.12.007","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T18:31:50Z","timestamp":1487788310000},"page":"630-636","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Manifestaciones cut\u00e1neas de la neurofibromatosis tipo 2: inter\u00e9s diagn\u00f3stico y pron\u00f3stico"],"prefix":"10.1016","volume":"108","author":[{"given":"A.","family":"Plana-Pla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Bielsa-Marsol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Carrato-Mo\u00f1ino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2016.12.007_bib0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-4-16","article-title":"Neurofibromatosis type 2 (NF2): A clinical and molecular review","volume":"4","author":"Evans","year":"2009","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ad.2016.12.007_bib0110","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1474-4422(07)70075-3","article-title":"Neurofibromatosis 1 and neurofibromatosis 2: A twenty first century perspective","volume":"6","author":"Ferner","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ad.2016.12.007_bib0115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.otc.2015.02.005","article-title":"Neurofibromatosis type 2","volume":"48","author":"Slattery","year":"2015","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.ad.2016.12.007_bib0120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-2005-837581","article-title":"Earliest clinical manifestations and natural history of neurofibromatosis type 2 (NF2) in childhood: A study of 24 patients","volume":"36","author":"Ruggieri","year":"2005","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.ad.2016.12.007_bib0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S1071-9091(98)80003-X","article-title":"The diagnosis and management of neurofibromatosis 2 in childhood","volume":"5","author":"MacCollin","year":"1998","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.ad.2016.12.007_bib0130","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1365-2133.2003.05249.x","article-title":"Multiples unilateral schwannomas: Segmental neurofibromatosis type 2 or schwannomatosis?","volume":"148","author":"Leverkus","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2016.12.007_bib0135","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1086\/342716","article-title":"Predictors of the risk mortality in neurofibromatosis 2","volume":"71","author":"Michael","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ad.2016.12.007_bib0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/02688690500081206","article-title":"Management of the patient and family with neurofibromatosis 2: A consensus conference statement","volume":"19","author":"Evans","year":"2005","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.ad.2016.12.007_bib0145","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/brain\/awf115","article-title":"Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2","volume":"125","author":"Sperfeld","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.ad.2016.12.007_bib0150","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/GIM.0b013e3181ac9a27","article-title":"Neurofibromatosis 2 (bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II)","volume":"11","author":"Evans","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.ad.2016.12.007_bib0155","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","article-title":"Neurofibromatosis type 2","volume":"6","author":"Asthagiri","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ad.2016.12.007_bib0160","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1365-2559.1998.00419.x","article-title":"Nerve sheath tumours with hybrid features of neurofibroma and schwannoma: A conceptual challenge","volume":"32","author":"Feany","year":"1998","journal-title":"Histopathology"},{"key":"10.1016\/j.ad.2016.12.007_bib0165","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/1097-0142(19951001)76:7<1181::AID-CNCR2820760713>3.0.CO;2-P","article-title":"Cutaneous plexiform schwannoma associated with neurofibromatosis type 2","volume":"76","author":"Fernando Val","year":"1995","journal-title":"Cancer"},{"year":"2012","series-title":"Tumores cut\u00e1neos de partes blandas","author":"Requena","key":"10.1016\/j.ad.2016.12.007_bib0170"},{"key":"10.1016\/j.ad.2016.12.007_bib0175","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/PAS.0b013e31824d3155","article-title":"Hybrid neurofibroma\/schwannoma is overrepresented among schwannomatosis and neurofibromatosis patients","volume":"36","author":"Harder","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2016.12.007_bib0180","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/ced.12306","article-title":"Cutaneous and ophtalmic signs as a clue to early diagnosis of severe neurofibromatosis type 2: Report of a novel mutation that predicts poor prognosis","volume":"39","author":"Casado-Verrier","year":"2014","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ad.2016.12.007_bib0185","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jmg.2006.047753","article-title":"Mosaicism in neurofibromatosis type 2: An update of risk based on uni\/bilaterality of vestibular schwannoma at presentation and sensitive mutation analysis including multiple ligation-dependent probe amplification","volume":"44","author":"Evans","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.ad.2016.12.007_bib0190","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12920-015-0076-2","article-title":"Segmental neurofibromatosis type 2: Discriminating two hit from four hit in a patient presenting multiple schwannomas confined to one limb","volume":"8","author":"Castellanos","year":"2015","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.ad.2016.12.007_bib0195","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/jmedgenet-2015-103290","article-title":"Clinical and molecular predictors of mortality in neurofibromatosis 2: A UK national analysis of 1,192 patients","volume":"52","author":"Hexter","year":"2015","journal-title":"J Med Genet"},{"key":"10.1016\/j.ad.2016.12.007_bib0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1399-0004.2009.01315.x","article-title":"Further genotype--phenotype correlations in neurofibromatosis 2","volume":"77","author":"Selvanathan","year":"2010","journal-title":"Clin Genet"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731017300455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731017300455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:05:58Z","timestamp":1757552758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731017300455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0001731017300455"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2016.12.007","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manifestaciones cut\u00e1neas de la neurofibromatosis tipo 2: inter\u00e9s diagn\u00f3stico y pron\u00f3stico","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2016.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 AEDV. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}